Home » Topics » Hematologic, BioWorld Science

Hematologic, BioWorld Science
RSS

Young blood not all it's cracked up to be

Jan. 22, 2020

Long-term safety and efficacy of AAV5-hFVIII-SQ gene therapy

Jan. 17, 2020

Nomacopan achieves primary endpoint at interim analysis of phase III CAPSTONE study

Jan. 13, 2020

Apellis announces positive topline data from phase III PEGASUS study of pegcetacoplan in PNH

Jan. 8, 2020

New humanized transgenic mouse model of FNAIT

Jan. 8, 2020

Mim8, an FVIII mimetic antibody, shows promise for hemophilia A

Jan. 7, 2020

Phase II data presented for sevuparin in SCD patients with acute painful vaso-occlusive crisis

Jan. 7, 2020

U.S. researchers present novel coagulation factor VIIa chimera for hemophilia patients

Jan. 2, 2020

Regeneron begins open-label extension study with REGN-3918 in PNH

Jan. 2, 2020

PGC-1alpha as a novel therapeutic target in sickle cell disease

Jan. 2, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Nov. 7, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for November 7, 2024.
Regulatory actions for Oct. 31, 2024
BioWorld
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Capsida, Electra,...
Australia reimburses Vazkepa a decade after US approval
BioWorld
For the first time, Australians have access to CSL Inc.’s Vazkepa (icosapent ethyl/Vascepa) for managing cardiovascular disease more than a decade after the drug...
Sanofi bets on Resalis’ oligonucleotide RES-010 for obesity
BioWorld
After missing out on the glucagon-like peptide 1 obesity market, Sanofi SA is prospecting for next-generation drugs and is making a strategic equity investment in...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.